Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

pengarang

René Bernards

Tycho Bismeijer

Magali Michaut

1982 -

Suet-feung Chin

Karin Jirström

1965 -

Carlos Caldas

1960 -

Mae A Goldgraben

Lodewyk F A Wessels

Ian J Majewski

Astrid Bosma

Tesa M Severson

Justine K Peeters

Philip C Schouten

Roelof J C Kluin

Jettie J F Muris

Sabine Linn

Ron M Kerkhoven

diterbitkan dalam: Molecular Oncology

tanggal publikasi: 2015-05-07

Cites articles 49

Date

Judul

Pengarang

2014-01-27

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Paul J van Diest
2014-12-05

Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapy.

Peter Sinn, Bauke Ylstra, Michael Hauptmann, Andreas Schneeweiss, Frederik Marmé
2014-11-03

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

Judith Balmaña, Susan M Domchek, Rita Schmutzler, Ronnie Shapira-Frommer
2014-05-06

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance

Hans Kristian Moen Vollan, Anne-Lise Børresen-Dale, Laxmi Silwal-Pandit, Vessela Kristensen, Anita Langerød, Carlos Caldas, Suet-feung Chin, Samuel Aparicio, Oscar M Rueda, Steven McKinney
2013-08-15

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

Funda Meric-Bernstam, Jennifer A. Pietenpol, Brian D. Lehmann, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
2013-04-04

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
2013-03-05

Novel functions of FoxM1: from molecular mechanisms to cancer therapy

Mónica Alvarez, René H. Medema
2013-05-14

Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.

Michael Hauptmann, Esther H Lips
2013-05-05

The shaping and functional consequences of the microRNA landscape in breast cancer.

Christina Curtis, Eric A Miska, Suet-feung Chin, Heidi Dvinge, Mali Salmon-Divon, Andrew Green, Ian Ellis, Carlos Caldas, Stefan Gräf, Elena Provenzano, Anna Git, Sam Aparicio, Yongjun Zhao, Gulisa Turashvili
2012-08-01

Understanding the biology of triple-negative breast cancer
2012-10-04

Comprehensive molecular portraits of human breast tumours

Hai Hu
2012-09-12

FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.

Aidong Zhou
2012-09-01

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
2012-07-24

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer

Brian D. Lehmann, Jennifer A. Pietenpol
2012-06-25

Modification of the DNA damage response by therapeutic CDK4/6 inhibition
2012-04-18

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Anne-Lise Børresen-Dale, Anita Langerød, Florian Markowetz, Carlos Caldas, Sarah E. Pinder, Ian Ellis, Christina Curtis, Suet-feung Chin, Alison Dunning
2012-04-04

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Gavin Ha, Damian Yap, Daniel Lai, Inanc Birol, Malachi Griffith, Gregg B Morin, Suet-feung Chin, Christina Curtis, John R. Mackey, Wyeth Wasserman, Steven Jones, Connie Eaves, Jiarui Ding, Samuel Aparicio, Oscar M Rueda, Sohrab P Shah, Paul D P Pharoah, Angela Burleigh, Yongjun Zhao, David Huntsman, Stephen K L Chia, Karey Shumansky, Gulisa Turashvili
2012-03-26

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

Reece J Goiffon, Aleix Prat
2011-11-15

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

Pascal Braun, Hans R. Widlund, Marc Vidal, Piotr Sicinski
2011-10-27

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Esther H Lips
2011-07-01

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann, Jennifer A. Pietenpol
2011-01-01

Triple-negative breast cancer: an unmet medical need,Triple-Negative Breast Cancer: An Unmet Medical Need

Luca Gianni
2011-08-19

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

Mark Clemons, Marc Tischkowitz, Blake Gilks
2010-12-06

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

Michael Hauptmann, Marc van de Vijver
2010-11-11

Triple-Negative Breast Cancer

Jorge Reis-Filho, William David Foulkes
2010-07-24

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Rita Schmutzler, Jeffrey N Weitzel, Mark Robson
2010-04-09

Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1.

René H. Medema, Shabaz Mohammed, Albert J.R. Heck, Lenno Krenning, Vincentius A Halim, Mónica Alvarez-Fernández, Melinda Aprelia
2010-01

FOXM1 confers acquired cisplatin resistance in breast cancer cells

Barrie Peck, Eric W-F Lam
2009-11-03

Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer

Marc van de Vijver, Jolien M. Bueno-de-Mesquita
2009

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Charles Ginther, Judy Dering, Dylan Conklin, Ondrej Kalous
2009-09-01

Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept
2009-12-04

Subtypes of familial breast tumours revealed by expression and copy number profiling

Charis Eng, Stephen Fox, Sean Grimmond, Peter T. Simpson, Sunil R Lakhani, Georgia Chenevix-Trench, Fergus J. Couch, Peter Devilee, kConFab Investigators

Artikel - wd:Q40907759

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut